KevinMD January 12, 2025
Imagine two patients are diagnosed with liver cancer on the same day. Both have similar tumors and overall health. The only difference? Their zip codes. While we’d like to believe that all patients in the United States receive standardized care regardless of location, the reality is far more complex. Where a patient lives—and more specifically, which health care system they can access—may fundamentally alter their treatment options and outcomes.
This disparity becomes particularly evident in emerging cancer treatments such as theragnostics. These innovative therapies combine diagnostic imaging with targeted treatment, often using radioactive particles to deliver radiation directly to tumors. While these treatments can offer hope to patients who previously had limited options, their availability and implementation vary dramatically across...
Today's Sponsors
Today's Sponsor